ClinicalTrials.govpublic full text
Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder
schizophrenia, schizoaffective disorder, metabolic markers, ziprasidone, diabetes, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994456
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.